Literature DB >> 29752835

Documentation of psychotropic pro re nata medication administration: An evaluation of electronic health records compared with paper charts and verbal reports.

Krystle Martin1,2, Elke Ham3, N Zoe Hilton3,4.   

Abstract

AIMS AND
OBJECTIVES: To describe the documentation of pro re nata (PRN) medication for anxiety and to compare documentation at two hospitals providing similar psychiatric services, one that used paper charts and another that used an electronic health record (EHR). We also assessed congruence between nursing documentation and verbal reports from staff about the PRN administration process.
BACKGROUND: The ability to accurately document patients' symptoms and the care given is considered a core competency of the nursing profession (Wilkinson, Nursing process and critical thinking, Saddle River, 2007); however, researchers have found poor concordance between nursing notes and verbal reports or observations of events (e.g., Marinis et al., 2010, J Clin Nurs, 19, 1544-1552) and considerable information missing (e.g., Marinis et al., 2010, J Clin Nurs, 19, 1544-1552). Additionally, the administration of PRN medication has consistently been noted to be poorly documented (e.g., Baker et al., 2008, J Clin Nurs, 17, 1122-1131).
DESIGN: The project was a mixed-method, two-phase study that collected data from two sites.
METHODS: In phase 1, nursing documentation of PRN medication administrations was reviewed in patient charts; phase 2 included verbal reports from staff about this practice.
RESULTS: Nurses using EHR documented more information than those using paper charts, including the reason for PRN administration, who initiated the administration, and effectiveness. There were some differences between written and verbal reports, including whether potential side effects were explained to patients prior to PRN administration.
CONCLUSIONS: We continue the calls for attention to be paid to improving the quality of nursing documentation. Our results support the shift to using EHR, yet not relying on this method completely to ensure comprehensiveness of documentation. RELEVANCE TO CLINICAL PRACTICE: Efforts to address the quality of documentation, particularly for PRN administration, are needed. This could be made through training, using structured report templates and by switching to electronic databases.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  documentation; electronic health record; inpatient; mental health; pro re nata

Mesh:

Substances:

Year:  2018        PMID: 29752835     DOI: 10.1111/jocn.14511

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

1.  Causality and avoidability of adverse drug reactions of antibiotics in hospitalized children: a cohort study.

Authors:  Sheila Feitosa Ramos; Fernando de Castro Araújo-Neto; Giulyane Targino Aires-Moreno; Dyego Carlos Souza Anacleto de Araújo; Elisângela da Costa Lima; Divaldo Pereira de Lyra
Journal:  Int J Clin Pharm       Date:  2021-03-03

2.  Prescribing errors among adult patients in a large tertiary care system in Saudi Arabia.

Authors:  Maryam Ali Alharaibi; Abdullah A Alhifany; Yousif A Asiri; Monira M Alwhaibi; Sheraz Ali; Parameaswari P Jaganathan; Tariq M Alhawassi
Journal:  Ann Saudi Med       Date:  2021-06-01       Impact factor: 1.526

Review 3.  PRN Medicines Management for Psychotropic Medicines in Long-Term Care Settings: A Systematic Review.

Authors:  Mojtaba Vaismoradi; Flores Vizcaya Moreno; Hege Sletvold; Sue Jordan
Journal:  Pharmacy (Basel)       Date:  2019-11-25

4.  Practical Considerations of PRN Medicines Management: An Integrative Systematic Review.

Authors:  Abbas Mardani; Piret Paal; Christiane Weck; Shazia Jamshed; Mojtaba Vaismoradi
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

Review 5.  Impact of Electronic Health Records on Information Practices in Mental Health Contexts: Scoping Review.

Authors:  Timothy Charles Kariotis; Megan Prictor; Shanton Chang; Kathleen Gray
Journal:  J Med Internet Res       Date:  2022-05-04       Impact factor: 7.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.